Recent Quotes (30 days)

You have no recent quotes
chg | %

GW Pharmaceuticals plc  

(Public, LON:GWP)   Watch this stock  
Find more results forGWP
LON real-time data - Disclaimer
Currency in
Range     -
52 week 211.00 - 950.00
Open     -
Vol / Avg. 0.00/956,721.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.24
Shares 302.09M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -1673.22% -617.13%
Operating margin -1940.09% -839.62%
EBITD margin - -1051.78%
Return on average assets -42.39% -17.14%
Return on average equity -48.31% -19.78%
Employees 496 -
CDP Score - -


Sovereign House Vision Park, Chivers Way
United Kingdom - Map
+44-1223-266800 (Phone)
+44-1223-235667 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform.

Officers and directors

Geoffrey W. Guy Executive Chairman of the Board
Age: 60
Justin Gover Chief Executive Officer, Director
Age: 43
Adam David George Chief Financial Officer, Company Secretary, Director
Age: 44
Christopher John Tovey Chief Operating Officer, Executive Director
Age: 49
Julian S. Gangolli Executive Director
Age: 59
James Julian Noble Non-Executive Deputy Chairman of the Board, Senior Independent Director
Age: 55
Cabot Brown Non-Executive Independent Director
Age: 53
Thomas Gerard Lynch Non-Executive Independent Director
Age: 58